Market Overview

Colorectal Cancer Diagnostic Market With Focus on DNA-Based Tests: Industry Analysis & Outlook Report 2018-2025 - ResearchAndMarkets.com

Share:

The "Colorectal
Cancer Diagnostic Market with Focus on DNA-Based Tests: Industry
Analysis & Outlook (2018-2025)"
report has been added to ResearchAndMarkets.com's
offering.

Colorectal Cancer Diagnostics Market with Focus on DNA-based Tests:
Industry Analysis & Outlook (2018-2025) provides an extensive research
and detailed analysis of the present market along with future outlook.
The report discusses the major growth drivers and challenges of the
market, covering the U.S., Europe and Asia.

Screening for colorectal cancer is effective not only for early
detection but also for prevention. Diagnosis of colorectal cancer
through screening tends to occur 2-3 years before diagnosis of cases
with symptoms. CRC Screening is broadly divided into Structural
Examination and Stool Tests. Structural examination is further divide
into Flexible Sigmoidography, Colonoscopy and Computed Tomographic
Colonography, whereas Stool Tests are divided into Occult blood and DNA
tests.

Colorectal Cancer Diagnostics Market is expected to grow in future due
to increasing disposable income, increasing aging population and cancer
incidences and rising healthcare expenditure. Key trends of this market
include launch of branded and advanced diagnosis and technology
innovation. However, there are some factors which can hinder the market
growth including stringent legal norms, high cost, need for high quality
of screening process and dearth of expertise.

The report profiles the key players of the market including Epigenomics,
Exact Sciences Corporation, VoilitionRx Ltd and Quest Diagnostics.

Key Topics Covered:

1. Introduction

1.1 Colorectal Cancer

1.2 Diagnosis

1.3 Treatment

2. Market Overview

2.1 Global Colorectal Cancer Incidences Forecast

2.2 CRC Death Averted per 1,000 Individuals Screened

2.3 Distribution of Colorectal Cases and Relative Survival

2.4 Colorectal Cancer Screening Test Types

3. The U.S. Colorectal Cancer Screening Market

3.1 The U.S. CRC Screening Eligible Patient Volume Forecast

3.2 The U.S. CRC Screening Receiving Patient Volume Forecast

3.3 The U.S. CRC Screening Test Market Volume Forecast

3.4 The U.S. CRC Screening Market Volume by Type

3.5 The U.S. CRC Screening Test Product Market

4. Europe Colorectal Cancer Screening Market

4.1 Europe CRC Screening Eligible Patient Volume Forecast

4.2 Europe CRC Screening Eligible Patient Volume by Country

4.3 Europe CRC Screening Receiving Patient Volume Forecast

4.4 Europe CRC Screening Test Product Market

5. Asia Colorectal Cancer Screening Market

5.1 Asia CRC Screening Eligible Patient Volume Forecast

5.2 Asia CRC Screening Test Product Market

6. Market Dynamics

6.1 Growth Drivers

6.1.1 Increasing Disposable Income

6.1.2 Acceleration of Ageing Population and Cancer Incident Cases

6.1.3 Rising Healthcare Expenditure

6.2 Key Trends

6.2.1 Launch of Branded and Advanced Diagnostic Tests

6.2.2 Technology Innovation

6.3 Challenges

6.3.1 Stringent Legal Norms

6.3.2 High Cost and Alternative Treatments

6.3.3 Need for High Quality of Screening Process

6.3.4 Dearth of Expertise

7. Competition

7.1 Global Market

7.1.1 Revenue Comparison of Key Players

7.1.3 DNA based CRC Screening Tests Comparison

8. Company Profiles

  • Exact Sciences Corporation
  • Volition Rx Ltd.
  • Epigenomics AG
  • Quest Diagnostics

For more information about this report visit https://www.researchandmarkets.com/research/22wmwx/colorectal_cancer?w=4

View Comments and Join the Discussion!